MADD antibody (AA 5-329) (APC)
Quick Overview for MADD antibody (AA 5-329) (APC) (ABIN8007809)
Target
See all MADD AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 5-329
-
Purpose
- Anti-MADD Antibody APC Conjugated
-
Purification
- Immunogen affinity purified.
-
Immunogen
- E.coli-derived human MADD recombinant protein (Position: K5-Y329).
-
Isotype
- IgG
-
-
-
-
Application Notes
- Flow Cytometry, Optimal dilutions should be determined by end users.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Each vial contains 50 % glycerol, 0.9 % NaCl, 0.2 % Na2HPO4, 0.02 % Sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- At -20°C for one year from date of receipt. Avoid repeated freezing and thawing. Protect from light.
-
Expiry Date
- 12 months
-
-
- MADD (MAP-Kinase Activating Death Domain (MADD))
-
Alternative Name
- MADD
-
Background
-
Background: MAP kinase-activating death domain protein is an enzyme that in humans is encoded by the MADD gene. Tumor necrosis factor alpha (TNF-alpha) is a signaling molecule that interacts with one of two receptors on cells targeted for apoptosis. The apoptotic signal is transduced inside these cells by cytoplasmic adaptor proteins. The protein encoded by this gene is a death domain-containing adaptor protein that interacts with the death domain of TNF-alpha receptor 1 to activate mitogen-activated protein kinase (MAPK) and propagate the apoptotic signal. It is membrane-bound and expressed at a higher level in neoplastic cells than in normal cells. Several transcript variants encoding different isoforms have been described for this gene.
Gene Full Name: MAP kinase activating death domain
-
Gene ID
- 8567
-
UniProt
- Q8WXG6
-
Pathways
- Caspase Cascade in Apoptosis
Target
-